Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Salix Pharmaceuticals Ltd. (SLXP)

NASDAQ: Health Care

Get a 5-page Ratings Report on (SLXP) now
$59.13 0.38 | 0.65%
Today's Range: 58.88 - 59.57
SLXP Avg. Daily Volume: 528,000
05/21/13 - 12:39 PM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: 48.99
  • Price Earnings Comparisons:
    SLXP Sector Avg. S&P 500
    48.99 49.00 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    21.00% 18.38% 59.40%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 36.10 2.16 0.46
    Net Income -26.50 -2.47 0.00
    EPS -29.90 -2.24 0.00
  • Earnings for SLXP:
    EBITDA 267,880,000
    REVENUE 735,444,000
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.82 $0.97 $3.59 $4.57
Number of Analysts 1 1 1 1
High Estimate $0.82 $0.97 $3.59 $4.57
Low Estimate $0.82 $0.97 $3.59 $4.57
Prior Year $0.79 $0.95 $3.00 $3.59
Growth Rate (Year over Year) 3.80% 2.11% 19.67% 27.30%
(SLXP) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,381.92 46.64 0.30%
NASDAQ 3,501.86 5.43 0.16%
S&P 500 1,669.44 3.15 0.19%
US 10 Yr 1.935% -0.030

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs